ArticlePoultry science2026
Timing of an antioxidant-acidifier feed additive modulates growth performance and cecal microbiota in broiler chickens during enrofloxacin exposure.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutritional interventions targeting oxidative stress and gut ecology may help sustain broiler performance during antimicrobial perturbation. This study evaluated the timing-dependent effects of an antioxidant-acidifier feed additive, alone or combined with enrofloxacin, on growth performance and cecal microbiota in broilers. A total of 1,200 Ross 308 male broilers were assigned to six treatments (4 pens/treatment; 50 birds/pen) and reared to 42 d: control, enrofloxacin (d15-19), additive for 4 weeks (A4; d15-42), A4+enrofloxacin, additive for 6 weeks (A6; d1-42), and A6+enrofloxacin. The additive was included at 4% of the diet, providing fumaric acid, heat-stable vitamin C, and all-rac-α-tocopheryl acetate. Performance traits were recorded by phase and overall. Cecal contents were collected from 2 birds/pen on d14, d20, and d42 and analyzed by shotgun metagenomic sequencing; microbiota analyses were conducted on pen-level aggregated profiles. Growth performance showed modest, timing-dependent numerical differences: A4 had numerically higher finisher and overall average daily gain, whereas A4+enrofloxacin was associated with lower overall gain than enrofloxacin alone. Cecal community structure was driven primarily by sampling time point. No detectable enrofloxacin-associated separation was observed at d20, whereas a trend toward separation was evident at d42. By d42, only limited genus-level differences were detected, with the strongest signal observed for Phocaeicola in the targeted differential abundance analysis. Overall, additive timing influenced growth responses and cecal microbiota trajectories during enrofloxacin exposure, supporting the importance of supplementation timing when nutritional strategies are used to improve robustness under antibiotic perturbation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.